HPS masthead
What's New?
. Fukushima Decontamination Report
. CRCPD & CDC Grants for Volunteer Corps
. America's Nuclear Future
. February Newsletter
. Boice Nominated President of NCRP
. February Journal
. February ORS
. Schauer Given the Butterfly Award from Image Gently
. Kase President's Report to IRPA
. IRPA13 Accepting Posters
Upcoming Events
. HPS Midyear - Issues in Waste Management
5-8 February 2012
Dallas, Texas
. NRC Regulatory Information Conference
NRC Regulatory Information Conference
13-15 March 2012
Rockville, Maryland
. NCRP Annual Meeting
12-13 March 2012
Washington, DC
. James E. Turner Memorial Symposium
Call for Abstracts
18-19 April 2012
Oak Ridge Associated Universities, Pollard Auditorium, Oak Ridge, Tennessee
. IRPA13
13-18 May 2012
Glasgow, Scotland
. Canadian Radiation Protection Association (CRPA) Annual Meeting
27-30 May 2012
Halifax, Nova Scotia
. ACS Undergrad Summer Schools
10 June- 20 July 2012
. Nuclear Regulatory Commission Meeting Webcasts
February 2012
Bethesda, Maryland
09 February 2012

Answer to Question #1387 Submitted to "Ask the Experts"

Category: Policy, Guidelines, and Regulations

The following question was answered by an expert in the appropriate field:

Q
In hospitals with nonpatient-related research laboratories where radioactive materials are used (for example, 10 mCi 32P in an experiment), how far from patient areas should the labs be? Our hospital is considering putting such a lab just around the corner from waiting rooms and other patient areas. It seems like a bad idea to me.
A
There are no specific requirements regarding the distance the laboratory must be from patient waiting areas. Because patients in waiting areas are members of the public, the only requirements in this case are those imposed on doses in unrestricted areas and dose limits to members of the public, as well as ALARA (as low as reasonably achievable). Specifically, Part 20 (Code of Federal Regulations, Title 10, Part 20) requires that doses to members of the public be limited to 100 mrem/yr and be kept ALARA. In addition, doses in unrestricted areas are to be below 2 mrem in any one hour. Therefore, if the lab meets these requirements at the proposed location, it may be established at that location, unless it can be shown that ALARA considerations dictate otherwise. From a radiological controls point of view it may be advisable to consider other, nonregulatory, factors. For example, if unsealed radioactive materials are to be used, ventilation and the flow of air out of the lab to the waiting areas would be an issue, as well as the potential spread of contamination into these areas and the control of access to the lab, which will likely be posted as a restricted area. Security of radioactive materials is also a consideration. Such factors may make establishing the lab at the proposed location less than ideal, but these are not strictly regulatory considerations, but rather organizational and pragmatic.

Sami Sherbini
Nuclear Regulatory Commission
Answer posted on 19 November 2001. The information and material posted on this website is intended as general reference information only. Specific facts and circumstances may alter the concepts and applications of materials and information described herein. The information provided is not a substitute for professional advice and should not be relied upon in the absence of such professional advice specific to whatever facts and circumstances are presented in any given situation. Answers are correct at the time they are posted on the Website. Be advised that over time, some requirements could change, new data could be made available, or Internet links could change. For answers that have been posted for several months or longer, please check the current status of the posted information prior to using the responses for specific applications.
image
image
Home Affiliates Ask the Experts Radiation Terms Employment Meetings